http://www.unboundmedicine.com/medline/ebm/research/RepronexUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/16280073/full_citation/Subcutaneously_administered_Menopur_a_new_highly_purified_human_menopausal_gonadotropin_causes_significantly_fewer_injection_site_reactions_than_Repronex_in_subjects_undergoing_in_vitro_fertilization_Keye WR, Webster B, Dickey R, et al. 
Subcutaneously administered Menopur, a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex in subjects undergoing in vitro fertilization. [Journal Article]
Reprod Biol Endocrinol 2005 Nov 9.:62.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/15864946/full_citation/Live_delivery_following_transfer_of_a_single_frozen_thawed_embryo_derived_from_a_42_year_old_woman_with_marked_decreased_oocyte_reserve_Check JH 
Live delivery following transfer of a single frozen-thawed embryo derived from a 42-year-old woman with marked decreased oocyte reserve. [Case Reports, Journal Article]
Clin Exp Obstet Gynecol 2005; 32(1):75-7.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/15302283/full_citation/Evaluation_of_mixed_protocols_with_Bravelle__human_derived_FSH__and_Repronex__hMG__to_assess_clinical_efficacy__EMBRACE__in_women_undergoing_in_vitro_fertilization_Keye WR, Marrs RP, Check JH, et al. 
Evaluation of mixed protocols with Bravelle (human-derived FSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Fertil Steril 2004 Aug; 82(2):348-57.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/12899646/full_citation/Urofollitropin___Ferring:_FERRING_hFSH_hFSH___Ferring_human_follicle_stimulating_hormone___Ferring_Bravelle_Urofollitropin - Ferring: FERRING hFSH, hFSH - Ferring, human follicle-stimulating hormone - Ferring, Bravelle. [Journal Article]
BioDrugs 2003; 17(4):288-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/11438320/full_citation/Subcutaneously_administered_Repronex_in_oligoovulatory_female_patients_undergoing_ovulation_induction_is_as_effective_and_well_tolerated_as_intramuscular_human_menopausal_gonadotropin_treatment_Nichols J, Knochenhauer E, Fein SH, et al. 
Subcutaneously administered Repronex in oligoovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Fertil Steril 2001 Jul; 76(1):58-66.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/10899500/full_citation/Subcutaneously_administered_Repronex_in_female_patients_undergoing_in_vitro_fertilization_is_as_effective_and_well_tolerated_as_intramuscular_menotropin_treatment__Repronex_SC_IVF_Study_Group_Gocial B, Keye WR, Fein SH, et al. 
Subcutaneously administered Repronex in female patients undergoing in vitro fertilization is as effective and well tolerated as intramuscular menotropin treatment. Repronex SC, IVF Study Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Fertil Steril 2000 Jul; 74(1):73-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles